Quick Answer
NeuroSense Therapeutics Ltd. reported Total Assets of $1.03 million for fiscal year 2025.
NeuroSense Therapeutics Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.03M | -77.5% |
| 2024 | $4.58M | +43.6% |
| 2023 | $3.19M | -58.7% |
| 2022 | $7.71M | -32.6% |
| 2021 | $11.43M | +1367.4% |
| 2020 | $779.0K | — |
- NeuroSense Therapeutics Ltd. showed a decrease of -77.5% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, NeuroSense Therapeutics Ltd.’s total assets has grown by 32.0% (from $779.0 thousand to $1.03 million).
- The most recent figure is from NeuroSense Therapeutics Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: